FANCELLI, SARA
FANCELLI, SARA
Medicina Sperimentale e Clinica
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma.
2018 Lavacchi D, Nobili S, Brugia M, Paderi A, Fancelli S, Caliman E, Vergoni F, Mini E.
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy
2022 Caliman, Enrico; Fancelli, Sara; Ottanelli, Carlotta; Mazzoni, Francesca; Paglialunga, Luca; Lavacchi, Daniele; Michelet, Marta Rita Gatta; Giommoni, Elisa; Napolitano, Brunella; Scolari, Federico; Voltolini, Luca; Comin, Camilla Eva; Pillozzi, Serena; Antonuzzo, Lorenzo
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma
2022 Pasqui, Adriano; Boddi, Anna; Campanacci, Domenico Andrea; Scoccianti, Guido; Bernini, Andrea; Grasso, Daniela; Gambale, Elisabetta; Scolari, Federico; Palchetti, Ilaria; Palomba, Annarita; Fancelli, Sara; Caliman, Enrico; Antonuzzo, Lorenzo; Pillozzi, Serena
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification
2023 Caliman, Enrico; Fancelli, Sara; Petroni, Giulia; Gatta Michelet, Marta Rita; Cosso, Federica; Ottanelli, Carlotta; Mazzoni, Francesca; Voltolini, Luca; Pillozzi, Serena; Antonuzzo, Lorenzo
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives
2021 Fancelli S.; Caliman E.; Mazzoni F.; Brugia M.; Castiglione F.; Voltolini L.; Pillozzi S.; Antonuzzo L.
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment
2020 Roviello G.; Casadei-Gardini A.; Nobili S.; Mini E.; Fancelli S.
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario
2022 Cantini, L; Mentrasti, G; Russo, G L; Signorelli, D; Pasello, G; Rijavec, E; Russano, M; Antonuzzo, L; Rocco, D; Giusti, R; Adamo, V; Genova, C; Tuzi, A; Morabito, A; Gori, S; Verde, N La; Chiari, R; Cortellini, A; Cognigni, V; Pecci, F; Indini, A; De Toma, A; Zattarin, E; Oresti, S; Pizzutilo, E G; Frega, S; Erbetta, E; Galletti, A; Citarella, F; Fancelli, S; Caliman, E; Della Gravara, L; Malapelle, U; Filetti, M; Piras, M; Toscano, G; Zullo, L; De Tursi, M; Di Marino, P; D'Emilio, V; Cona, M S; Guida, A; Caglio, A; Salerno, F; Spinelli, G; Bennati, C; Morgillo, F; Russo, A; Dellepiane, C; Vallini, I; Sforza, V; Inno, A; Rastelli, F; Tassi, V; Nicolardi, L; Pensieri, V; Emili, R; Roca, E; Migliore, A; Galassi, T; Rocchi, M L Bruno; Berardi, R
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer
2022 Antonuzzo, Lorenzo; Caliman, Enrico; Petrella, Maria Cristina; Rossi, Virginia; Mazzoni, Francesca; Grosso, Anna Maria; Fancelli, Sara; Paglialunga, Luca; Comin, Camilla; Roviello, Giandomenico; Pillozzi, Serena
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment
2022 Gambale, Elisabetta; Fancelli, Sara; Caliman, Enrico; Petrella, Maria Cristina; Doni, Laura; Pillozzi, Serena; Antonuzzo, Lorenzo
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor)
2019 Gasperoni S, Messerini L, Fumagalli E, Manglaviti S, Vincenzi B, Mazzocca Jr. A, Pantaleo MA, Nannini M, Badalamenti G, Incorvaia L, Ottaviano M, Palmieri G, Grignani G, D'Ambrosio L, Meoni G, Paderi A, Fancelli S, Caliman E, Tofani L, Enrico Mini.
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions
2022 Lavacchi, Daniele; Caliman, Enrico; Rossi, Gemma; Buttitta, Eleonora; Botteri, Cristina; Fancelli, Sara; Pellegrini, Elisa; Roviello, Giandomenico; Pillozzi, Serena; Antonuzzo, Lorenzo
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population
2022 Fancelli, Sara; Caliman, Enrico; Mazzoni, Francesca; Paglialunga, Luca; Gatta Michelet, Marta Rita; Lavacchi, Daniele; Berardi, Rossana; Mentrasti, Giulia; Metro, Giulio; Birocchi, Ilaria; Delmonte, Angelo; Priano, Ilaria; Comin, Camilla Eva; Castiglione, Francesca; Bartoli, Caterina; Voltolini, Luca; Pillozzi, Serena; Antonuzzo, Lorenzo
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients
2022 Fancelli, S; Roviello, G; Castiglione, F; Caliman, E; Mazzoni F, null; Paglialunga L, null; Pillozzi, S; Antonuzzo, L
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer
2023 Cosso, Federica; Lavacchi, Daniele; Fancelli, Sara; Caliman, Enrico; Brugia, Marco; Rossi, Gemma; Winchler, Costanza; Pillozzi, Serena; Antonuzzo, Lorenzo
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
2022 Lavacchi, Daniele; Fancelli, Sara; Roviello, Giandomenico; Castiglione, Francesca; Caliman, Enrico; Rossi, Gemma; Venturini, Jacopo; Pellegrini, Elisa; Brugia, Marco; Vannini, Agnese; Bartoli, Caterina; Cianchi, Fabio; Pillozzi, Serena; Antonuzzo, Lorenzo
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma
2024 Cosso, Federica; Lavacchi, Daniele; Messerini, Luca; Briganti, Vittorio; Castiglione, Francesca; Brugia, Marco; Berti, Valentina; Fancelli, Sara; Cianchi, Fabio; Vannini, Agnese; Pillozzi, Serena; Antonuzzo, Lorenzo
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing
2023 Lavacchi, Daniele; Fancelli, Sara; Buttitta, Eleonora; Vannini, Gianmarco; Guidolin, Alessia; Winchler, Costanza; Caliman, Enrico; Vannini, Agnese; Giommoni, Elisa; Brugia, Marco; Cianchi, Fabio; Pillozzi, Serena; Roviello, Giandomenico; Antonuzzo, Lorenzo
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing
2023 Lavacchi, Daniele; Fancelli, Sara; Buttitta, Eleonora; Vannini, Gianmarco; Guidolin, Alessia; Winchler, Costanza; Caliman, Enrico; Vannini, Agnese; Giommoni, Elisa; Brugia, Marco; Cianchi, Fabio; Pillozzi, Serena; Roviello, Giandomenico; Antonuzzo, Lorenzo
REBECA trial: A new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer
2020 Lavacchi D.; Fancelli S.; Michelet M.R.G.; Catalano M.; Roviello G.
Results of the observational prospective RealFLOT study
2021 Giommoni, Elisa; Lavacchi, Daniele; Tirino, Giuseppe; Fornaro, Lorenzo; Iachetta, Francesco; Pozzo, Carmelo; Satolli, Maria Antonietta; Spallanzani, Andrea; Puzzoni, Marco; Stragliotto, Silvia; Sisani, Michele; Formica, Vincenzo; Giovanardi, Filippo; Strippoli, Antonia; Prisciandaro, Michele; Di Donato, Samantha; Pompella, Luca; Pecora, Irene; Romagnani, Alessandra; Fancelli, Sara; Brugia, Marco; Pillozzi, Serena; De Vita, Ferdinando; Antonuzzo, Lorenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. | 2018 | Lavacchi D, Nobili S, Brugia M, Paderi A, Fancelli S, Caliman E, Vergoni F, Mini E. | |
| Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy | 2022 | Caliman, Enrico; Fancelli, Sara; Ottanelli, Carlotta; Mazzoni, Francesca; Paglialunga, Luca; Lavacchi, Daniele; Michelet, Marta Rita Gatta; Giommoni, Elisa; Napolitano, Brunella; Scolari, Federico; Voltolini, Luca; Comin, Camilla Eva; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma | 2022 | Pasqui, Adriano; Boddi, Anna; Campanacci, Domenico Andrea; Scoccianti, Guido; Bernini, Andrea; Grasso, Daniela; Gambale, Elisabetta; Scolari, Federico; Palchetti, Ilaria; Palomba, Annarita; Fancelli, Sara; Caliman, Enrico; Antonuzzo, Lorenzo; Pillozzi, Serena | |
| Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification | 2023 | Caliman, Enrico; Fancelli, Sara; Petroni, Giulia; Gatta Michelet, Marta Rita; Cosso, Federica; Ottanelli, Carlotta; Mazzoni, Francesca; Voltolini, Luca; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives | 2021 | Fancelli S.; Caliman E.; Mazzoni F.; Brugia M.; Castiglione F.; Voltolini L.; Pillozzi S.; Antonuzzo L. | |
| Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment | 2020 | Roviello G.; Casadei-Gardini A.; Nobili S.; Mini E.; Fancelli S. | |
| Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario | 2022 | Cantini, L; Mentrasti, G; Russo, G L; Signorelli, D; Pasello, G; Rijavec, E; Russano, M; Antonuzzo, L; Rocco, D; Giusti, R; Adamo, V; Genova, C; Tuzi, A; Morabito, A; Gori, S; Verde, N La; Chiari, R; Cortellini, A; Cognigni, V; Pecci, F; Indini, A; De Toma, A; Zattarin, E; Oresti, S; Pizzutilo, E G; Frega, S; Erbetta, E; Galletti, A; Citarella, F; Fancelli, S; Caliman, E; Della Gravara, L; Malapelle, U; Filetti, M; Piras, M; Toscano, G; Zullo, L; De Tursi, M; Di Marino, P; D'Emilio, V; Cona, M S; Guida, A; Caglio, A; Salerno, F; Spinelli, G; Bennati, C; Morgillo, F; Russo, A; Dellepiane, C; Vallini, I; Sforza, V; Inno, A; Rastelli, F; Tassi, V; Nicolardi, L; Pensieri, V; Emili, R; Roca, E; Migliore, A; Galassi, T; Rocchi, M L Bruno; Berardi, R | |
| Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer | 2022 | Antonuzzo, Lorenzo; Caliman, Enrico; Petrella, Maria Cristina; Rossi, Virginia; Mazzoni, Francesca; Grosso, Anna Maria; Fancelli, Sara; Paglialunga, Luca; Comin, Camilla; Roviello, Giandomenico; Pillozzi, Serena | |
| Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment | 2022 | Gambale, Elisabetta; Fancelli, Sara; Caliman, Enrico; Petrella, Maria Cristina; Doni, Laura; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) | 2019 | Gasperoni S, Messerini L, Fumagalli E, Manglaviti S, Vincenzi B, Mazzocca Jr. A, Pantaleo MA, Nannini M, Badalamenti G, Incorvaia L, Ottaviano M, Palmieri G, Grignani G, D'Ambrosio L, Meoni G, Paderi A, Fancelli S, Caliman E, Tofani L, Enrico Mini. | |
| Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions | 2022 | Lavacchi, Daniele; Caliman, Enrico; Rossi, Gemma; Buttitta, Eleonora; Botteri, Cristina; Fancelli, Sara; Pellegrini, Elisa; Roviello, Giandomenico; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population | 2022 | Fancelli, Sara; Caliman, Enrico; Mazzoni, Francesca; Paglialunga, Luca; Gatta Michelet, Marta Rita; Lavacchi, Daniele; Berardi, Rossana; Mentrasti, Giulia; Metro, Giulio; Birocchi, Ilaria; Delmonte, Angelo; Priano, Ilaria; Comin, Camilla Eva; Castiglione, Francesca; Bartoli, Caterina; Voltolini, Luca; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients | 2022 | Fancelli, S; Roviello, G; Castiglione, F; Caliman, E; Mazzoni F, null; Paglialunga L, null; Pillozzi, S; Antonuzzo, L | |
| Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer | 2023 | Cosso, Federica; Lavacchi, Daniele; Fancelli, Sara; Caliman, Enrico; Brugia, Marco; Rossi, Gemma; Winchler, Costanza; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer | 2022 | Lavacchi, Daniele; Fancelli, Sara; Roviello, Giandomenico; Castiglione, Francesca; Caliman, Enrico; Rossi, Gemma; Venturini, Jacopo; Pellegrini, Elisa; Brugia, Marco; Vannini, Agnese; Bartoli, Caterina; Cianchi, Fabio; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma | 2024 | Cosso, Federica; Lavacchi, Daniele; Messerini, Luca; Briganti, Vittorio; Castiglione, Francesca; Brugia, Marco; Berti, Valentina; Fancelli, Sara; Cianchi, Fabio; Vannini, Agnese; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing | 2023 | Lavacchi, Daniele; Fancelli, Sara; Buttitta, Eleonora; Vannini, Gianmarco; Guidolin, Alessia; Winchler, Costanza; Caliman, Enrico; Vannini, Agnese; Giommoni, Elisa; Brugia, Marco; Cianchi, Fabio; Pillozzi, Serena; Roviello, Giandomenico; Antonuzzo, Lorenzo | |
| Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing | 2023 | Lavacchi, Daniele; Fancelli, Sara; Buttitta, Eleonora; Vannini, Gianmarco; Guidolin, Alessia; Winchler, Costanza; Caliman, Enrico; Vannini, Agnese; Giommoni, Elisa; Brugia, Marco; Cianchi, Fabio; Pillozzi, Serena; Roviello, Giandomenico; Antonuzzo, Lorenzo | |
| REBECA trial: A new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer | 2020 | Lavacchi D.; Fancelli S.; Michelet M.R.G.; Catalano M.; Roviello G. | |
| Results of the observational prospective RealFLOT study | 2021 | Giommoni, Elisa; Lavacchi, Daniele; Tirino, Giuseppe; Fornaro, Lorenzo; Iachetta, Francesco; Pozzo, Carmelo; Satolli, Maria Antonietta; Spallanzani, Andrea; Puzzoni, Marco; Stragliotto, Silvia; Sisani, Michele; Formica, Vincenzo; Giovanardi, Filippo; Strippoli, Antonia; Prisciandaro, Michele; Di Donato, Samantha; Pompella, Luca; Pecora, Irene; Romagnani, Alessandra; Fancelli, Sara; Brugia, Marco; Pillozzi, Serena; De Vita, Ferdinando; Antonuzzo, Lorenzo |